SUNY, WPI & UConn v. Huawei Device: 7-Patent Wearable Health Tech Suit Dismissed Without Prejudice
Three U.S. research universities jointly sued Huawei Device Co. in the Eastern District of Texas, asserting seven patents covering wearable biosensor and health-monitoring technology across 20 Huawei smartwatch and fitness-band products. After 427 days, the plaintiffs voluntarily dismissed all claims without prejudice — leaving the door open for refiling.
Three universities, seven biosensor patents, and one early exit in East Texas
Filed on 22 November 2023, this action in the Eastern District of Texas saw The Research Foundation for the State University of New York, Worcester Polytechnic Institute, and the University of Connecticut jointly assert seven U.S. patents — US9713428B2, US8417326B2, US9408576B2, US10278647B2, US10285601B2, US9986921B2, and US10653362B2 — against Huawei Device Co., Ltd. The patents cover wearable biosensor and physiological health-monitoring technologies, and the complaint targeted 20 distinct Huawei products including the Watch GT series, Watch 4 Series, Watch D, Watch Ultimate, and Band 7 and Band 8.
On 22 January 2025, plaintiffs filed a Notice of Dismissal under Federal Rule of Civil Procedure 41(a)(1)(A)(i), voluntarily dismissing all claims without prejudice. The court accepted and acknowledged the notice, formally closing the case and denying all pending relief as moot. Critically, the dismissal was without prejudice, meaning the universities have not relinquished their substantive patent rights and retain the ability to refile these same claims in the same or a different forum.
The 427-day duration — resolved before any reported Markman hearing or trial setting — suggests the parties may have reached a private resolution, or that plaintiffs elected to withdraw ahead of a potentially unfavourable procedural development. The public record is silent on whether a settlement was reached, a licensing agreement concluded, or strategic considerations led to withdrawal. No defendant law firm appeared on the docket, which may indicate Huawei did not formally contest the action before the dismissal was filed.
Filing to Voluntary dismissal in 427 days
427 days from filing to closure — shorter than the median E.D. Tex. patent case, suggesting early resolution before substantial merits litigation.
Voluntarily dismissed: what the without-prejudice ruling means for both parties
Rule 41(a)(1)(A)(i): dismissal as of right, before the defendant answers
Under Fed. R. Civ. P. 41(a)(1)(A)(i), a plaintiff may dismiss an action without a court order by filing a notice before the opposing party serves an answer or motion for summary judgment. This procedural mechanism requires no judicial approval and takes immediate effect. The absence of a defendant law firm on the docket is consistent with Huawei not having formally responded — making this route available to plaintiffs without opposition.
No court order neededWithout prejudice vs. with prejudice: why the distinction matters
A dismissal without prejudice does not adjudicate the merits and does not bar refiling. A dismissal with prejudice, by contrast, operates as a final judgment on the merits and extinguishes the claim. The verdict here is explicit that dismissal is WITHOUT PREJUDICE. The public record does not disclose whether a private settlement, licence, or other agreement accompanied this dismissal — the docket is silent on any such terms.
Refiling remains availablePatent rights preserved — enforcement optionality retained
SUNY Research Foundation, WPI, and UConn retain full ownership and enforceability of all seven asserted patents. The dismissal without prejudice means no adverse ruling, no claim construction, and no invalidity finding has been entered against any of these patents. Plaintiffs may refile in E.D. Texas, transfer to a different district, or pursue licensing negotiations backed by the same patent portfolio.
Portfolio fully intactHuawei escapes judgment — but faces latent refileability risk
Huawei Device obtains closure on this specific proceeding and faces no damages award or injunction. However, the without-prejudice dismissal means the 20 named products remain potentially exposed to a future infringement action on the same seven patents. Huawei’s apparent decision not to formally appear may reflect a strategic calculation — or undisclosed negotiations — but leaves no favourable precedent on the record.
No judgment, latent exposureFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | The Research Foundation for the State University of New York | Individual | University consortium — joint holders of 7 wearable biosensor and health-monitoring patentsSearch in Eureka ↗ |
| Co-Plaintiff | Worcester Polytechnic Institute | Individual | Search in Eureka ↗ |
| Co-Plaintiff | University of Connecticut | Individual | Search in Eureka ↗ |
| Defendant | Huawei Device Co., Ltd. | Company | Huawei Device Co., Ltd. — Chinese consumer electronics manufacturer, wearables divisionSearch in Eureka ↗ |
| Plaintiff counsel | Andrea Leigh Fair | Attorney | Counsel for The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Plaintiff counsel | Christopher Reed Clayton | Attorney | Counsel for The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Plaintiff counsel | Claire Abernathy Henry | Attorney | Counsel for The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Plaintiff counsel | Joseph J. Gribbin | Attorney | Counsel for The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Plaintiff counsel | Timothy Devlin | Attorney | Counsel for The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Plaintiff law firm | Armstrong Teasdale LLP | Law Firm | Representing The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Plaintiff law firm | Devlin Law Firm LLC | Law Firm | Representing The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Plaintiff law firm | Devlin Law Firm LLC (Wilmington) | Law Firm | Representing The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Plaintiff law firm | Miller Fair Henry PLLC | Law Firm | Representing The Research Foundation for the State University of New YorkSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s order accepting the Rule 41(a)(1)(A)(i) notice is a purely procedural disposition — no claim was construed, no validity ruling was made, and no infringement finding was entered. The explicit ‘WITHOUT PREJUDICE’ designation is dispositive: the seven patents remain fully enforceable and all twenty named Huawei products remain exposed to a future action. The instruction that each party bear its own costs is standard for voluntary dismissals at this stage and does not signal any concession by either side on the merits.
US9713428B2 and six further patents — wearable biosensor and physiological monitoring
The seven asserted patents — US9713428B2, US8417326B2, US9408576B2, US10278647B2, US10285601B2, US9986921B2, and US10653362B2 — collectively cover wearable biosensor technology for continuous physiological monitoring. The portfolio spans application dates from as early as US12/671847 through to US15/985912, reflecting incremental innovation in sensor hardware, signal processing, and health data acquisition methods developed across three research institutions over more than a decade.
For the wearables sector, this portfolio is strategically significant because it encompasses foundational biosensing methods that underpin optical heart rate monitoring, blood oxygen measurement, and related physiological data functions now standard in consumer smartwatches and fitness bands. The multi-assignee structure — SUNY, WPI, and UConn — means licensing negotiations would require coordination across three institutions, raising the complexity and cost of any patent challenge or licence negotiation for a potential infringer.
Should you run an FTO against US9713428B2 and the six co-asserted biosensor patents?
Any company developing or sourcing wearable devices with integrated optical heart rate sensors, SpO2 measurement, ECG functionality, or related physiological monitoring features should assess freedom to operate against this seven-patent portfolio. The 20 Huawei products named in this case span the full range of consumer smartwatch form factors — from entry-level fitness bands to premium ceramic and titanium watches — suggesting the claims are drafted broadly enough to reach multiple product tiers.
PatSnap Eureka’s FTO Search Agent can map each of the seven patent families against your product specifications and bill-of-materials data, identify design-around opportunities at the claim element level, and flag continuation or divisional applications that may extend the risk window. With a without-prejudice dismissal leaving enforcement optionality open, proactive FTO analysis now is significantly less costly than litigation defence later.
Run a freedom-to-operate analysis on US9713428B2 to assess your product’s exposure
Run FTO in Eureka →Similar wearable biosensor patent cases in E.D. Texas and related courts
Explore comparable university-led patent assertions targeting wearable health-monitoring technology in the Eastern District of Texas and other high-activity patent venues.
What this case signals for the wearable health-tech IP landscape
Seven biosensor patents, 20 smartwatch products, and a clean exit: this case raises questions every wearables IP team should consider.
University consortiums are pooling patents for coordinated wearables enforcement
The joint assertion by SUNY, WPI, and UConn signals a coordinated university licensing strategy in wearable health technology. When research institutions pool portfolios, the breadth of claim coverage increases significantly — competitors should map their products against multi-institution patent clusters, not individual university portfolios in isolation.
Without-prejudice dismissal is not a safe harbour for accused products
All 20 Huawei wearable products named in this complaint remain at risk of future assertion. Companies that see a competitor’s case dismissed without prejudice should treat the outcome as a pause, not a clearance. Running a freedom-to-operate analysis on the seven asserted patents is advisable before expanding product lines in biosensor-integrated wearables.
York v Huawei — key questions answered
The case was dismissed WITHOUT PREJUDICE. Plaintiffs filed a voluntary notice of dismissal under Rule 41(a)(1)(A)(i) on 22 January 2025. The court accepted the notice and formally closed the case, but the without-prejudice designation means all seven asserted patents remain enforceable and the same claims could be refiled against Huawei or its products in the future.
The plaintiffs asserted seven U.S. patents: US9713428B2, US8417326B2, US9408576B2, US10278647B2, US10285601B2, US9986921B2, and US10653362B2. These patents collectively cover wearable biosensor and physiological health-monitoring technologies, including sensor hardware, signal acquisition, and data-processing methods relevant to smartwatch and fitness-band products.
Twenty Huawei products were named, including the Watch GT series (GT2, GT2 Pro, GT2e, GT3, GT3 Pro Ceramic, GT3 Pro Titanium, GT3 SE, GT Cyber, GT Runner), Watch 3, Watch 3 Pro, Watch 4 Series, Watch D, Watch FIT variants (FIT Mini, FIT Special Edition, FIT new, Fit 2), Watch Ultimate, Band 7, and Band 8.
The public record does not disclose the reason for dismissal. Possible explanations include a confidential settlement or licensing agreement, a strategic decision to refile in a different forum, or withdrawal ahead of an adverse procedural ruling. No defendant counsel appeared on the docket, which is notable and may be relevant to the timing of the dismissal.
Rule 41(a)(1)(A)(i) allows a plaintiff to dismiss as of right before the defendant files an answer or motion for summary judgment. A dismissal under this rule is without prejudice unless the notice states otherwise. Here, the notice expressly stated without prejudice, meaning the seven patents are unaffected and could support new infringement claims against Huawei or other defendants in the future.
PatSnap Eureka searches patents and litigation data to answer instantly.